HELSINKI, June 2025 — MVision AI, a provider of cloud-based AI solutions for radiotherapy planning, has secured a €2.8 million loan from Business Finland R&D. The investment will strengthen MVision AI’s product development efforts and fast-track its vision — enabling same-day cancer treatment by cutting the time from simulation to treatment from several weeks to just a few hours.
Business Finland’s R&D funding supports SMEs and midcap companies in developing innovative technologies with strong potential for international growth. These loans help companies gain a competitive edge when developing new products, services, or business models.
MVision AI’s GBS™ Guideline-Based Segmentation Suite includes Contour+, an AI-powered auto-contouring tool, as well as Guide, a training environment for developing contouring expertise, and Verify, a tool for assessing contour accuracy. GBS™ integrates easily into existing radiotherapy workflows without the need for complex local infrastructure. MVision AI’s technology is currently used in over 22 countries and has supported treatment planning for more than 190,000 cancer patients. The company also offers Dose+, a machine learning-based tool that helps clinicians personalize and optimize radiotherapy dose plans.
Mahmudul Hasan, Founder and Executive Director of MVision AI, commented: “We are grateful for the support from Business Finland R&D. This loan will help us accelerate our work toward making same-day radiotherapy a practical reality. By investing in cloud-based innovation, we can continue to improve the speed and quality of care available to cancer patients.”
Asko Schrey, MVision AI board member and investor, added: “It’s been rewarding to witness MVision AI’s progress over the past eight years. I’m proud to support the team as both an investor and a board member as they continue advancing innovations that have real impact in cancer care.”
With this funding, MVision AI continues to build on its mission to improve cancer care through automation, standardization, and clinician-focused solutions that help deliver high-quality treatment faster and more efficiently.
For more information, visit www.mvision.ai or contact info@mvision.ai.
About MVision AI
MVision AI is a leading provider of AI-powered solutions for radiation therapy treatment planning. Our mission is to empower Radiation Oncology professionals with cutting-edge technology to streamline workflows, enhance treatment quality, and facilitate more patient-focused care. With a commitment to innovation and excellence, MVision AI continues to advance cancer care through the power of AI.